Ribosomal protein L7a pseudogene 22 (RPL7AP22)

Ribosomal protein L7a pseudogene 22 (RPL7AP22) is a pseudogene derived from the gene encoding ribosomal protein L7a (RPL7A), which is a component of the large 60S ribosomal subunit[3][6]. Pseudogenes such as RPL7AP22 are typically non-functional, do not code for an active protein, and are generally considered to lack biological activity[3]. They are dispersed throughout the genome as remnants of gene duplication or retrotransposition events and do not have established roles as therapeutic targets, biomarkers, or modulators of disease[3][9]. If your intent was to query about the functional ribosomal protein L7a, that would be the RPL7A gene itself, not its pseudogene ("RPL7AP22")[5][7][11]. There is no evidence that RPL7AP22 encodes a functional protein or is involved in any disease mechanism, biomarker strategy, drug interaction, or therapeutic targeting[3][6][9]. The entry is included in gene databases due to sequence homology with the protein-coding RPL7A gene, but "RPL7AP22" itself is not a canonical gene product nor a protein[3][6]. Summary: RPL7AP22 is a human processed pseudogene related to the ribosomal protein L7a gene and has no function as a protein, drug target, or biomarker; the query appears to reflect a mistaken identity if interpreted as a functional target[3][6].

Other names

RPL7A_4_289RPL7AP22